Diabetic revascularization: endovascular versus open bypass--do we have the answer?

Area of Science:

• Vascular Surgery
• Diabetic Complications
• Peripheral Arterial Disease

Background:

• Diabetes is a major risk factor for peripheral arterial disease (PAD), increasing limb and life threats, especially with advanced disease, tissue loss, and infection.
• Managing severe limb ischemia in diabetic patients presents significant surgical challenges.
• The distinct pattern of lower extremity atherosclerosis in diabetes influences revascularization strategies.

Purpose of the Study:

• To review the management of severe limb ischemia in diabetic patients.
• To discuss revascularization strategies considering the unique atherosclerotic patterns in diabetes.
• To evaluate the role of open reconstruction versus endovascular interventions.

Main Methods:

• Review of current literature and clinical practices for managing diabetic patients with critical limb ischemia.
• Analysis of revascularization strategies, including infrapopliteal angioplasty and bypass surgery.
• Consideration of factors influencing treatment choices such as patient risk, disease extent, and conduit availability.

Main Results:

• Aggressive multidisciplinary care and revascularization can avoid major amputations in many diabetic patients.
• Autogenous vein bypass is often the gold standard for revascularization, offering proven durability.
• Infrapopliteal angioplasty is viable for select lesions, but high restenosis rates remain a concern.

Conclusions:

• A selective revascularization strategy, prioritizing autogenous vein bypass, is advocated for its efficacy and durability.
• Endovascular therapies play a crucial role and may become more prominent if restenosis issues are addressed.
• Vascular specialists must master both open and endovascular techniques to optimize outcomes for diabetic patients with PAD.